Key takeaways
- The side effects of progesterone most often reported in menopausal hormone therapy are headache, breast tenderness, dizziness, drowsiness, bloating and low mood.
- The side effects of progesterone pills differ from other forms mainly in drowsiness and dizziness, because swallowed progesterone is converted into calming metabolites as it is absorbed.
- Progesterone 200 mg side effects are the ones in the label's main table, because 200 mg was the dose given 12 days a month with estrogen in that three-year trial.
- Too much progesterone side effects are mainly heavier versions of the common ones, especially drowsiness and dizziness, and there are no human overdose studies.
- For most healthy women under 60 or within 10 years of menopause without contraindications, hormone therapy that includes a progestogen has a favorable benefit-risk ratio for bothersome hot flashes, but progesterone carries label contraindications and its own long-term safety data come mostly from observational studies.
Short Answer
What Are the Side Effects of Progesterone?
The side effects of progesterone most often reported in menopausal hormone therapy are headache, breast tenderness, dizziness, drowsiness, bloating and low mood. The FDA label for Prometrium, the brand of oral micronized progesterone, lists most of these from a three-year placebo-controlled trial and drowsiness in its precautions, and MedlinePlus advises reporting the common ones if they are severe or do not go away. A smaller set of symptoms, such as sudden swelling or pain in an arm or leg, chest pain, shortness of breath, face drooping, trouble speaking, a sudden severe headache or vision changes, a new breast lump, unexpected vaginal bleeding, or hives with swelling of the face or throat, are uncommon and need urgent care (MedlinePlus).
This page covers oral micronized progesterone, the form used alongside estrogen after menopause. The label describes it as chemically identical to progesterone made by the ovary (Prometrium label). It is a different drug from synthetic progestins such as medroxyprogesterone acetate, which was the progestin in the Women's Health Initiative trial, and the two should not be read as interchangeable. Pregnancy, IVF and birth-control uses are outside the scope of this guide.
Protocol Health prescribes hormone therapy for women, which can include progesterone, so we have a commercial interest in this topic, and this page gives the risks the same space as the benefits. If you want to know whether hormone therapy fits you, our short assessment is the first step.
| Reported effect | Progesterone 200 mg plus estrogen | Placebo |
|---|---|---|
| Headache | 31% | 27% |
| Breast tenderness | 27% | 6% |
| Depression | 19% | 12% |
| Dizziness | 15% | 9% |
| Abdominal bloating | 12% | 5% |
| Vaginal discharge | 10% | 3% |
| Worry | 8% | 4% |
| Hot flashes | 11% | 35% |
Bottom line: the most common progesterone side effects are mild and predictable, and the label's placebo arm shows that some, such as headache, are only a little more common on treatment than on placebo.
Most Common
Most Common Side Effects of Progesterone
The most common side effects of progesterone in the label's main trial were headache, breast tenderness, depression, dizziness and bloating, and of these breast tenderness showed the widest gap from placebo. In that trial of 875 postmenopausal women, breast tenderness was reported by 27% on progesterone with estrogen against 6% on placebo, and bloating by 12% against 5% (Prometrium label).
Some reported effects were no more common on treatment. Headache was reported by 31% on treatment and 27% on placebo, abdominal pain by 10% in both groups, and joint pain and hot flashes were less common on treatment, which reflects the estrogen in the active arm (Prometrium label). That is the value of a placebo group: a symptom that shows up while taking a drug is not always caused by it.
A second, smaller label trial used a higher dose. In 49 estrogen-primed postmenopausal women given 400 mg a day or placebo, dizziness was reported by 24% against 4%, abdominal cramping by 20% against 13%, headache by 16% against 8% and breast pain by 16% against 8% (Prometrium label). With 25 women on the drug, each of those percentages rests on a handful of people.
The label's precautions add two effects that are not in the tables: progesterone may cause some fluid retention, and it may cause transient dizziness and drowsiness, which is why it is taken as a single dose at bedtime (Prometrium label). The common side effects of progesterone cluster around the breasts, the gut, mood and alertness, and the placebo comparisons show breast tenderness and dizziness are the most clearly treatment-related, with estrogen also in the active arm.
Pills
Side Effects of Progesterone Pills
The side effects of progesterone pills differ from other forms mainly in drowsiness and dizziness, because swallowed progesterone is converted into calming metabolites as it is absorbed.
In a study of eight postmenopausal women given oral micronized progesterone, blood levels of progesterone and its metabolites peaked between two and six hours after the dose, and five metabolites with known anesthetic properties were identified. One woman given 400 mg went into a hypnotic state lasting about two hours. The authors concluded that the sedative effect of oral progesterone may be mediated through those metabolites, which act on the same GABA-A receptor system as sleep medicines (Andréen 2009).
That sedation can be useful. In a randomized crossover study of 10 postmenopausal women, 300 mg of oral micronized progesterone at night for 21 days reduced time spent awake during the night on sleep EEG and did not impair cognitive performance the next day. It was a small study, and it measured sleep, not side effects, but it explains why the label tells women to take the pill at bedtime and to use caution driving or operating machinery (Prometrium label). Our guide to why progesterone is taken at night covers timing in more detail.
The label also notes that during initial therapy a few women have had a cluster of symptoms including extreme dizziness or drowsiness, blurred vision, slurred speech, difficulty walking, confusion or loss of consciousness (Prometrium label). If that happens, contact your prescriber right away and do not drive. The capsule itself matters too. Prometrium capsules contain peanut oil and are contraindicated in anyone allergic to peanuts (Prometrium label). Progesterone pill side effects are mostly a sedation story, which bedtime dosing turns to an advantage for many women, though a few react strongly at the start and a peanut allergy rules the capsule out entirely.
In Women
Progesterone Side Effects in Women After Menopause
Progesterone side effects in women after menopause most often show up as mood changes, breast tenderness and bloating, and a minority of women are clearly more sensitive than others.
Mood is the effect that varies most between women. A review of sex-steroid-induced mood symptoms describes how certain women develop negative mood, irritability or anxiety when progesterone or a progestin is added to hormone therapy, most likely through its metabolite allopregnanolone acting on GABA-A receptors. The relationship looks like an inverted U: adverse mood appears at blood levels similar to the second half of a menstrual cycle, with less effect at lower and higher levels. The same review notes that only some women react this way, and women with premenstrual dysphoric disorder appear especially sensitive.
The label's trial is consistent with that picture: depression was reported by 19% of women on progesterone with estrogen against 12% on placebo, and worry by 8% against 4% (Prometrium label). Those figures come from symptom reports, not psychiatric diagnoses, and the active group also took estrogen. The label's post-marketing reports also include suicidal ideation (Prometrium label); anyone with thoughts of self-harm should seek help immediately, including by calling or texting 988.
Weight is the other common concern. The label notes that progesterone may cause some fluid retention (Prometrium label), and our guide to progesterone weight gain separates fluid from fat. Progesterone side effects in women after menopause are real for some and absent for many, and a history of PMS or premenstrual mood symptoms is worth telling your physician before starting.
By Dose
Progesterone 200 mg Side Effects
Progesterone 200 mg side effects are the ones in the label's main table, because 200 mg was the dose given 12 days a month with estrogen in that three-year trial.
The label's two adverse-reaction tables come from 200 mg and 400 mg regimens. At 200 mg with estrogen, breast tenderness, dizziness, bloating and low mood were the clearest differences from placebo; at 400 mg, dizziness was reported by 24% against 4% on placebo (Prometrium label). These are the doses the trials tested, not a regimen to follow.
The label does not include a separate side-effect table for 100 mg, so progesterone 100 mg side effects have not been measured against placebo in the label itself. Oral micronized progesterone at 300 mg nightly was studied for hot flashes in a 12-week randomized trial of 133 women, where 8 women on progesterone and 4 on placebo stopped because of adverse events, with no serious cases.
Across the doses that were studied, the sedating effects appear to rise with dose, and a physician sets the dose and schedule based on whether the goal is protecting the uterus, treating symptoms or both.
Too Much
Too Much Progesterone Side Effects
Too much progesterone side effects are mainly heavier versions of the common ones, especially drowsiness and dizziness, and there are no human overdose studies.
The Prometrium label states that no studies on overdosage have been conducted in humans, and that in an overdose the capsules should be stopped and symptoms treated (Prometrium label). The best evidence on higher doses is the label's 400 mg trial, where dizziness was six times as common as on placebo (6 of 25 women against 1 of 24), and the single woman in the metabolite study who went into a hypnotic state for about two hours after 400 mg.
More is not always worse for mood, though. The allopregnanolone review describes adverse mood peaking at middle concentrations, so a woman who feels low on progesterone is not necessarily taking too much. Excess progesterone shows up first as sedation, and anyone who has taken more than prescribed and feels very drowsy or confused should get medical help.
Safety
Is Progesterone Safe?
For most healthy women under 60 or within 10 years of menopause without contraindications, hormone therapy that includes a progestogen has a favorable benefit-risk ratio for bothersome hot flashes, but progesterone carries label contraindications and its own long-term safety data come mostly from observational studies.
The Prometrium label contraindicates it in women with a peanut allergy, abnormal genital bleeding of unknown cause, known or suspected breast cancer, active or past blood clots in the legs or lungs, active or past stroke or heart attack, and liver disease (Prometrium label). It tells prescribers to stop it immediately if a clot, stroke or heart attack occurs or is suspected.
The risks most people associate with hormone therapy come from the Women's Health Initiative, which tested conjugated estrogens with medroxyprogesterone acetate, a synthetic progestin. After an average of 5.2 years, that combination raised the risk of breast cancer (hazard ratio 1.26), stroke (1.41) and pulmonary embolism (2.13) compared with placebo. The Prometrium label states that the relevance of those findings to other progestogen products is not known and that the risks cannot be excluded (Prometrium label).
Observational studies suggest micronized progesterone may behave differently from synthetic progestins. In the French E3N cohort of 80,377 postmenopausal women, estrogen plus progesterone was not associated with higher breast cancer risk (relative risk 1.00), while estrogen with other progestins was (1.69). In the ESTHER case-control study, micronized progesterone was not significantly associated with venous clots (odds ratio 0.7), while norpregnane progestins were. A US claims study of 36,061 women, co-authored by an employee of Theramex, which markets a combined estradiol and progesterone pill, found a lower clot rate on that pill than on conjugated estrogens with medroxyprogesterone (incidence rate ratio 0.70). None of these are randomized trials, so they show association, not proof.
Progesterone's main safety job is protecting the uterus. In the randomized PEPI trial, women with a uterus who took estrogen alone developed atypical hyperplasia at 11.8% against 0% on placebo, while those given estrogen with a progestogen, including micronized progesterone 200 mg for 12 days a month, had hyperplasia rates similar to placebo. The same trial found estrogen with cyclic micronized progesterone had the most favorable effect on HDL cholesterol of the combined regimens (PEPI 1995). The 2022 North American Menopause Society position statement adds that hormone therapy risks differ by type, dose, duration, route, timing and whether a progestogen is used, and that the benefit-risk ratio is favorable for most women under 60 or within 10 years of menopause who have bothersome hot flashes and no contraindications.
Progesterone is as safe as the woman, the indication and the estrogen it is paired with, which is why the decision belongs to a physician who has your history.
FDA Status
Is Progesterone FDA Approved?
Oral micronized progesterone is FDA approved, sold as Prometrium and its generics, for two uses: preventing endometrial hyperplasia in postmenopausal women with a uterus who take conjugated estrogens, and treating secondary amenorrhea.
Those are the indications on the Prometrium label. Pairing progesterone with a different estrogen, such as estradiol, or taking it alone for hot flashes or sleep falls outside the label's wording and is a physician's off-label decision. The hot-flash use has randomized evidence behind it: in the 133-woman trial, 300 mg nightly reduced hot flash and night sweat scores more than placebo over 12 weeks.
Compounded progesterone, including custom capsules, creams and troches, is a different matter. The FDA's compounding questions and answers state that compounded drugs are not FDA-approved, which means the FDA has not reviewed their safety, effectiveness or quality before they are sold. The adverse-reaction figures on this page come from the approved oral capsule and may not apply to other forms.
On FDA status, oral micronized progesterone is an approved drug often used off-label, while compounded versions sit outside the FDA approval process altogether.
Reducing Them
How to Reduce Side Effects of Progesterone
How to reduce side effects of progesterone starts with taking it exactly as prescribed at bedtime and reporting side effects that persist, so your physician can adjust the plan rather than you stopping on your own.
Bedtime dosing is built into the label because of transient dizziness and drowsiness, and the label advises caution with driving or operating machinery (Prometrium label). MedlinePlus advises telling your doctor if headache, breast tenderness, stomach upset, tiredness, mood changes or vaginal discharge are severe or do not go away (MedlinePlus).
What a physician can change depends on why the progesterone was prescribed. Because hormone therapy risks and tolerability differ by type, dose, route and schedule (NAMS 2022), options can include a different dose or schedule, a different form of progestogen, or a different overall plan. Women whose mood clearly worsens on progesterone may be in the sensitive group the allopregnanolone review describes, which is worth raising directly rather than putting up with.
Reducing progesterone side effects is a conversation with your prescriber, not a change to make alone, because for a woman taking estrogen with a uterus the progesterone is doing a protective job.
Stopping
Stopping Progesterone Side Effects
Stopping progesterone side effects depend on whether you also take estrogen: alone, stopping did not cause a rebound in hot flashes in one trial, but stopping it while staying on estrogen leaves the uterus unprotected.
In a withdrawal substudy of the progesterone hot-flash trial, 34 women stopped progesterone or placebo and were followed for a month. On progesterone, hot flashes increased gradually after stopping, and four weeks later they were still at 78% of their pre-treatment level, below baseline. The authors concluded that progesterone does not cause a rebound in hot flashes when stopped. It was a small, one-month follow-up.
For a woman with a uterus taking estrogen, the bigger risk is stopping progesterone and continuing estrogen. In the PEPI trial, estrogen alone led to simple hyperplasia in 27.7%, complex hyperplasia in 22.7% and atypical hyperplasia in 11.8% of women, against under 1% on placebo. Unexpected vaginal bleeding is one of the symptoms MedlinePlus lists as a reason to call a doctor promptly (MedlinePlus).
Stopping progesterone is usually uneventful on its own, and it should be planned with your physician whenever estrogen is part of the regimen.
Our Approach
Progesterone Side Effects at Protocol Health
Progesterone side effects at Protocol Health are discussed before anything is prescribed and tracked afterward, as part of a physician-led hormone therapy plan for women. Protocol Health prescribes hormone therapy, which can include progesterone, so we have a commercial interest in this topic, and a physician may decide progesterone or hormone therapy is not right for you.
Our related guides cover low progesterone symptoms, whether you can take progesterone without estrogen and why progesterone is taken at night.
In-person care is at our Scarsdale, NY clinic, and telehealth visits are available in New York, New Jersey, Connecticut, Florida and California. Start with our short assessment to see whether a consultation fits.
Progesterone side effects at Protocol Health are handled the same way as the decision to start it: with your history, your symptoms and the evidence on the table.
FAQ
Frequently Asked Questions
Can progesterone cause depression?
It can in some women. In the label's three-year trial, 19% on progesterone with estrogen reported depression against 12% on placebo. Researchers link this to a progesterone metabolite acting on GABA-A receptors, and only a minority of women seem sensitive.
Can progesterone cause headaches?
Headache is the most reported effect, but it was only slightly more common than on placebo in the label's main trial: 31% against 27%. In a smaller 400 mg trial it was 16% against 8%.
Can progesterone cause bloating?
Yes. Bloating was reported by 12% on progesterone with estrogen against 5% on placebo in the label's trial, and the label notes progesterone may cause some fluid retention.
How long do progesterone side effects last?
No trial in the label measured how long they last. The label describes dizziness and drowsiness as transient, and MedlinePlus advises telling your doctor about side effects that are severe or do not go away.
Is micronized progesterone the same as a progestin?
No. Micronized progesterone is chemically identical to the progesterone the ovary makes. Progestins such as medroxyprogesterone acetate are synthetic, and observational studies suggest their breast cancer and clot risks may differ.
Is progesterone safe after menopause?
For most healthy women under 60 or within 10 years of menopause, hormone therapy including a progestogen has a favorable benefit-risk balance, per the 2022 NAMS statement. It is contraindicated with breast cancer, past clots, stroke, heart attack, liver disease or a peanut allergy.
Explore
Related at Protocol Health
Talk to a physician about hormone therapyMedical disclaimer
This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.
Important safety information
References
- FDA label for Prometrium. National Institutes of Health. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1cf237ff-c4f8-4faa-a7aa-77599c856889
- MedlinePlus. medlineplus.gov. https://medlineplus.gov/druginfo/meds/a604017.html
- Women's Health Initiative trial. PubMed. https://pubmed.ncbi.nlm.nih.gov/12117397/
- study of eight postmenopausal women. PubMed. https://pubmed.ncbi.nlm.nih.gov/3189454/
- Andréen 2009. PubMed. https://pubmed.ncbi.nlm.nih.gov/19272715/
- randomized crossover study of 10 postmenopausal women. PubMed. https://pubmed.ncbi.nlm.nih.gov/18676087/
- 12-week randomized trial of 133 women. PubMed. https://pubmed.ncbi.nlm.nih.gov/22453200/
- E3N cohort of 80,377 postmenopausal women. PubMed. https://pubmed.ncbi.nlm.nih.gov/17333341/
- ESTHER case-control study. PubMed. https://pubmed.ncbi.nlm.nih.gov/17309934/
- US claims study of 36,061 women. PubMed. https://pubmed.ncbi.nlm.nih.gov/37084589/
Show all 15 references
- PEPI trial. PubMed. https://pubmed.ncbi.nlm.nih.gov/8569016/
- PEPI 1995. PubMed. https://pubmed.ncbi.nlm.nih.gov/7807658/
- 2022 North American Menopause Society position statement. PubMed. https://pubmed.ncbi.nlm.nih.gov/35797481/
- FDA's compounding questions and answers. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
- withdrawal substudy of the progesterone hot-flash trial. PubMed. https://pubmed.ncbi.nlm.nih.gov/22849758/
Why trust our physicians
Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.
- Medically reviewed by
- Richard Dentico, MD on
- Written by
- Protocol Health Editorial Team
- First published
- Last updated
See an error? Email care@protocolhealthmd.com and we will review it.
More on Women's Hormones & HRT
- Estradiol Levels in Men: Normal Range, High and Low
- How to Choose a Menopause Doctor in Westchester, NY
- Can You Take Progesterone Without Estrogen?
- Estriol vs Estradiol: Which Estrogen Does What
